Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | NRAS |
Variant | R164C |
Impact List | missense |
Protein Effect | no effect - predicted |
Gene Variant Descriptions | NRAS R164C lies within the G domain of the Nras protein (PMID: 17384584). R164C results in MAPK/ERK pathway activation similar to wild-type Nras in an in vitro assay (PMID: 34117033), and therefore, is predicted to have no effect on Nras protein function. |
Associated Drug Resistance | |
Category Variants Paths |
NRAS mutant NRAS R164C |
Transcript | NM_002524.5 |
gDNA | chr1:g.114708615G>A |
cDNA | c.490C>T |
Protein | p.R164C |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_002524.4 | chr1:g.114708615G>A | c.490C>T | p.R164C | RefSeq | GRCh38/hg38 |
NM_002524.5 | chr1:g.114708615G>A | c.490C>T | p.R164C | RefSeq | GRCh38/hg38 |
NM_002524 | chr1:g.114708615G>A | c.490C>T | p.R164C | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|